63,768 Shares in Cardinal Health, Inc. $CAH Acquired by Navellier & Associates Inc.

Navellier & Associates Inc. bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 63,768 shares of the company’s stock, valued at approximately $13,104,000. Cardinal Health makes up about 1.5% of Navellier & Associates Inc.’s holdings, making the stock its 13th largest holding.

A number of other large investors have also recently added to or reduced their stakes in CAH. Wellington Management Group LLP boosted its holdings in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Holocene Advisors LP boosted its holdings in Cardinal Health by 141.4% during the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after buying an additional 1,128,358 shares in the last quarter. Barclays PLC lifted its position in shares of Cardinal Health by 109.3% in the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after acquiring an additional 827,446 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock valued at $149,504,000 after acquiring an additional 708,995 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Cardinal Health by 44.9% in the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after acquiring an additional 707,495 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Leerink Partners restated an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. JPMorgan Chase & Co. reduced their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday. Argus upped their price target on shares of Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Citigroup reduced their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research report on Friday. Finally, Wells Fargo & Company reduced their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $241.80.

Cardinal Health Trading Down 0.0%

Cardinal Health stock opened at $196.97 on Wednesday. The company has a market capitalization of $46.13 billion, a P/E ratio of 30.12, a P/E/G ratio of 1.17 and a beta of 0.53. The firm’s fifty day simple moving average is $213.19 and its 200-day simple moving average is $206.47. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.